ミズーリ州における高血圧の臨床試験
ミズーリ州内の拠点で、高血圧に関する11件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- CRO Call Center, Overland
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07142356EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Jefferson City Medical Group, Jefferson City
- Johnson County ClinTrials, Kansas City
- St. Louis Heart and Vascular, P.C., St Louis
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Clinvest Headlands Llc, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Kansas City
- Research Site, Kansas City
- Research Site, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- St Lukes Hospital, Kansas City
被験者募集中
22歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Kansas City
- Clinical Trial Site, Kansas City
- Clinical Trial Site, Kansas City
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109Impact GLP-1 Agonists Following Bariatric
- University of Missouri Hospital, Columbia
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06132477Global Paradise System US Post Approval Study
- Saint Luke's Mid America Heart Institute, Kansas City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- University of Missouri, Columbia
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2026/08/07更新 · NCT06402968An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Jefferson City Medical Group, Jefferson City
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07543120Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Hazelwood
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/02/27更新 · NCT07090161ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。